157 related articles for article (PubMed ID: 8596827)
1. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.
Vinnicombe SJ; MacVicar AD; Guy RL; Sloane JP; Powles TJ; Knee G; Husband JE
Radiology; 1996 Feb; 198(2):333-40. PubMed ID: 8596827
[TBL] [Abstract][Full Text] [Related]
2. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.
Helvie MA; Joynt LK; Cody RL; Pierce LJ; Adler DD; Merajver SD
Radiology; 1996 Feb; 198(2):327-32. PubMed ID: 8596826
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy may eradicate ductal carcinoma in situ (DCIS) but not the associated microcalcifications.
Goldberg H; Zandbank J; Kent V; Leonov-Polak M; Livoff A; Chernihovsky A; Guindy M; Evron E
Eur J Surg Oncol; 2017 Aug; 43(8):1415-1420. PubMed ID: 28526187
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
Peintinger F; Kuerer HM; Anderson K; Boughey JC; Meric-Bernstam F; Singletary SE; Hunt KK; Whitman GJ; Stephens T; Buzdar AU; Green MC; Symmans WF
Ann Surg Oncol; 2006 Nov; 13(11):1443-9. PubMed ID: 17028770
[TBL] [Abstract][Full Text] [Related]
5. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.
An YY; Kim SH; Kang BJ
World J Surg Oncol; 2017 Nov; 15(1):198. PubMed ID: 29110671
[TBL] [Abstract][Full Text] [Related]
6. The use of mammography in breast preservation in locally advanced breast cancer.
Pierce L; Adler D; Helvie M; Lichter A; Merajver S
Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):571-7. PubMed ID: 8621280
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.
Evans A; Pinder S; Wilson R; Sibbering M; Poller D; Elston C; Ellis I
AJR Am J Roentgenol; 1994 Jun; 162(6):1307-11. PubMed ID: 8191988
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ of the breast: mammographic-pathologic correlation.
Poplack SP; Wells WA
AJR Am J Roentgenol; 1998 Jun; 170(6):1543-9. PubMed ID: 9609171
[No Abstract] [Full Text] [Related]
9. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations.
Barreau B; de Mascarel I; Feuga C; MacGrogan G; Dilhuydy MH; Picot V; Dilhuydy JM; de Lara CT; Bussières E; Schreer I
Eur J Radiol; 2005 Apr; 54(1):55-61. PubMed ID: 15797293
[TBL] [Abstract][Full Text] [Related]
10. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
11. Invasive breast cancer: mammographic measurement.
Flanagan FL; McDermott MB; Barton PT; Pilgram TK; Dehdashti F; Wick MR; Monsees BS
Radiology; 1996 Jun; 199(3):819-23. PubMed ID: 8638011
[TBL] [Abstract][Full Text] [Related]
12. Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.
Evans AJ; Pinder S; Ellis IO; Sibbering M; Elston CW; Poller DN; Wilson R
Radiology; 1994 Apr; 191(1):237-40. PubMed ID: 8134579
[TBL] [Abstract][Full Text] [Related]
13. Mammography in the assessment of response to medical treatment of large primary breast cancer.
Moskovic EC; Mansi JL; King DM; Murch CR; Smith IE
Clin Radiol; 1993 May; 47(5):339-44. PubMed ID: 8508597
[TBL] [Abstract][Full Text] [Related]
14. Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ.
Carlson KL; Helvie MA; Roubidoux MA; Kleer CG; Oberman HA; Wilson TE; Pollak EW; Rochester AB
AJR Am J Roentgenol; 1999 Feb; 172(2):313-7. PubMed ID: 9930774
[TBL] [Abstract][Full Text] [Related]
15. [Differences between clinical response and pathologic response of breast cancer after neoadjuvant chemotherapy].
Zheng S; Zhang BL; Zhang RZ; Yang JL; Zou SM; Xue LY; Luo W; Yuan YL; Lü N
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):734-8. PubMed ID: 21215162
[TBL] [Abstract][Full Text] [Related]
16. Small (< 2.0-cm) breast cancers: mammographic and US findings at US-guided cryoablation--initial experience.
Roubidoux MA; Sabel MS; Bailey JE; Kleer CG; Klein KA; Helvie MA
Radiology; 2004 Dec; 233(3):857-67. PubMed ID: 15567802
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of changes in breast architecture after preoperative chemotherapy for breast cancer.
McConeghey JF; Cusick TE; Helmer SD; Tenofsky PL; Osland JS
Am J Surg; 2012 Dec; 204(6):902-8; discussion 908-9. PubMed ID: 23026383
[TBL] [Abstract][Full Text] [Related]
18. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
von Minckwitz G; Untch M; Blohmer JU; Costa SD; Eidtmann H; Fasching PA; Gerber B; Eiermann W; Hilfrich J; Huober J; Jackisch C; Kaufmann M; Konecny GE; Denkert C; Nekljudova V; Mehta K; Loibl S
J Clin Oncol; 2012 May; 30(15):1796-804. PubMed ID: 22508812
[TBL] [Abstract][Full Text] [Related]
19. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy].
Sinn HP; Schmid H; Junkermann H; Huober J; Leppien G; Kaufmann M; Bastert G; Otto HF
Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):552-8. PubMed ID: 8001751
[TBL] [Abstract][Full Text] [Related]
20. Stability of malignant breast microcalcifications.
Lev-Toaff AS; Feig SA; Saitas VL; Finkel GC; Schwartz GF
Radiology; 1994 Jul; 192(1):153-6. PubMed ID: 8208928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
